John Cush/rheumnow.com
Jan 11, 2026, 06:59
John Cush: Subcutaneous Anifrolumab Effective in Lupus
John Cush, Executive Editor at RheumNow.com, shared a post on LinkedIn:
“Subcutaneous Anifrolumab Effective in Lupus
A new study published in Arthritis and Rheumatology demonstrates that subcutaneous administration of anifrolumab provides efficacy comparable to intravenous administration, offering a promising alternative for at-home care of patients living with moderate-to-severe SLE.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 27, 2026, 13:45Alberto Sifuentes Giraldo: Innovative CAR–T Cell Therapy Promises SLE Remission and Fertility
-
Feb 27, 2026, 13:27Ovarian Reserve’s Impact on Miscarriage Risk – RBMO
-
Feb 27, 2026, 13:12ACOG’s Outstanding Editorial Team for Menopause – ACOG
-
Feb 27, 2026, 11:26Phase-Dependent Cytokine Dynamics of Endometrium – Fertility and Sterility
-
Feb 27, 2026, 08:51Pregnancy with Lupus Is No Longer a Distant Possibility – The Lupus Foundation of Australia
-
Feb 27, 2026, 08:43Celebrate Your Triumphs: Share Your Joyful Milestones – ASRM
-
Feb 27, 2026, 08:30Exploring Maternal Mental Health and Neonatal Risks in SSRI Study – AJOG MFM
-
Feb 27, 2026, 08:25Trust in Data, Trust in Science: Webinar on Research Integrity and Patient Safety – ESHRE
-
Feb 27, 2026, 08:13Have You Registered for Our Next Journal Webinar Yet? – RBMO